sabarubicin has been researched along with vinorelbine in 1 studies
Studies (sabarubicin) | Trials (sabarubicin) | Recent Studies (post-2010) (sabarubicin) | Studies (vinorelbine) | Trials (vinorelbine) | Recent Studies (post-2010) (vinorelbine) |
---|---|---|---|---|---|
29 | 5 | 4 | 50 | 0 | 31 |
Protein | Taxonomy | sabarubicin (IC50) | vinorelbine (IC50) |
---|---|---|---|
Tubulin beta-4A chain | Homo sapiens (human) | 1.35 | |
Cholinesterase | Homo sapiens (human) | 0.7 | |
Tubulin beta chain | Homo sapiens (human) | 1.35 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
Tubulin alpha-3C chain | Homo sapiens (human) | 1.35 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
Substance-K receptor | Homo sapiens (human) | 1.6062 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.7 | |
Tubulin alpha-1B chain | Homo sapiens (human) | 1.35 | |
Tubulin alpha-4A chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-4B chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-3 chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-2A chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-8 chain | Homo sapiens (human) | 1.35 | |
Tubulin alpha-3E chain | Homo sapiens (human) | 1.35 | |
Tubulin alpha-1A chain | Homo sapiens (human) | 1.35 | |
Tubulin alpha-1C chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-6 chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-2B chain | Homo sapiens (human) | 1.35 | |
Tubulin beta-1 chain | Homo sapiens (human) | 1.35 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for sabarubicin and vinorelbine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |